Benitec Biopharma Limited Made Headway
Fri, Feb 07, 2020 at 05:30 PM
Benitec Biopharma Limited (BNTC:NASDAQ) rocketted at $7.44, representing a gain of 40.6%. On Thu 06 Feb 20, BNTC:NASDAQ hit a New 2-Week High of $5.29. The stock appeared on our News Catalysts scanner on Fri 31 Jan 20 at 09:18 AM in the 'EARNINGS' category. From Thu 16 Jan 20, the stock recorded 57.14% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Benitec Biopharma Limited (BNTC:NASDAQ)
Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.
Top 10 Gainers:
- LightPath Technologies, Inc. (LPTH:NASDAQ), 51.28%
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 46.15%
- Benitec Biopharma Limited (BNTC:NASDAQ), 40.64%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 32.23%
- Youdao, Inc. (DAO:NYSE), 29.12%
- Telenav, Inc. (TNAV:NASDAQ), 27.22%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 26.94%
- Collegium Pharmaceutical, Inc. (COLL:NASDAQ), 25.37%
- Ocwen Financial Corporation (OCN:NYSE), 24.3%
- Synaptics Incorporated (SYNA:NASDAQ), 20.58%